James R. Musick - Nov 11, 2022 Form 3 Insider Report for Vitro Biopharma, Inc. (NONE)

Role: Chief Science Officer, Director, 10%+ Owner
Signature: /s/ James R. Musick
Stock symbol: NONE
Transactions as of: Nov 11, 2022
Transactions value $: $0
Form type: 3
Date filed: 11/14/2022, 01:28 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NONE	Common Stock						2.34M	Nov 11, 2022	Direct
holding	NONE	Common Stock						22.7M	Nov 11, 2022	By Trust	F1
holding	NONE	Common Stock						2.96M	Nov 11, 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NONE	Employee Stock Option (Right to Buy)							Nov 11, 2022	Common Stock	4.3M	$0.05	Direct	F2
holding	NONE	Employee Stock Option (Right to Buy)							Nov 11, 2022	Common Stock	1M	$0.50	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held by the James R. Musick Trust, of which James R. Musick serves as the sole trustee and beneficiary.
F2	The option became exercisable as to (i) 860,000 shares on May 1, 2018, (ii) 860,000 shares on May 1, 2019, (iii) 860,000 shares on May 1, 2020, (iv) 860,000 shares on May 1, 2021, and (v) 860,000 shares on May 1, 2022.
F3	The option became exercisable as to 200,000 shares on November 30, 2021, and will become exercisable as to (i) 200,000 shares on November 30, 2022, (ii) 200,000 shares on November 30, 2023, (iii) 200,000 shares on November 30, 2024 and (iv) 200,000 shares on November 30, 2025.